Global Health Limited (MEDANTA) Gross Profit 2023–TTM

Name: Global Health Limited (MEDANTA) gross profit history 2023-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-10-22

Global Health Limited annual gross profit for fiscal TTM was ₹36.3 billion, an increase of 9.3% from ₹33.2 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

MEDANTA Annual Gross Profit

Gross Profit (annual)	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Gross Profit	₹36.3B	₹33.2B	₹27.6B	₹24.8B	₹20.6B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MEDANTA Quarterly Gross Profit

Gross Profit (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Gross Profit	₹10.1B	₹9.1B	₹8.7B	₹8.4B	₹7.9B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Gross Profit at Comparable Companies

MAXHEALTH Gross Profit — Max Healthcare Institute Limited
ASTERDM Gross Profit — Aster DM Quality Care Limited
FORTIS Gross Profit — Fortis Healthcare Limited
NH Gross Profit — Narayana Hrudayalaya Limited
BDMS Gross Profit — Bangkok Dusit Medical Services Public Company Limited
KIMS Gross Profit — Krishna Institute of Medical Sciences Limited

More MEDANTA metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow

All MEDANTA financial statements → Interactive MEDANTA charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.